Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMCJNRL)

Drug Name

BAY1251152 Drug Info

Synonyms

YZCUMZWULWOUMD-UHFFFAOYSA-N; SCHEMBL15720569; (rac)-5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine; 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine

Indication

Disease Entry	ICD 11	Status	REF
Haematological malignancy	2B33.Y	Phase 1	[1]

Cross-matching ID

PubChem CID: 74767009
CAS Number: CAS 1610358-59-2
TTD Drug ID: DMCJNRL

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Positive transcription elongation factor b (P-TEFb)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BAY1143572	DMVPAZ7	Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Positive transcription elongation factor b (P-TEFb)	TTQ7ABG	CDK9_HUMAN-CCNT1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.